Altratech selected to join EIC Pavilion at MEDICA 2026 in Düsseldorf
Cork diagnostics company to showcase its unified multimodal biomarker detection platform in
Hall 15, Booth C47, from 16 to 19 November 2026
Cork, Ireland, 5 November 2026.
Altratech has been selected by the European Innovation Council (EIC) to join the EIC Pavilion at MEDICA 2026, to showcase its technology at one of the world’s leading trade fairs for medical technology and healthcare. The event will take place in Messe Düsseldorf Exhibition Centre, Germany, from 16 to 19 November 2026.
Altratech will showcase its unified platform for multimodal diagnostic biomarker detection in Hall 15, Booth C47. The Altratech team will be on site throughout the event, with CEO Dr. Tara Dalton joining them to meet potential partners, collaborators and other leaders from across the global diagnostics and healthcare community.
“MEDICA brings together the international medical technology and diagnostics community at a scale that few other events can match. Joining the EIC Pavilion gives Altratech an excellent platform to demonstrate our technology, engage with prospective partners and build relationships that can support the next stage of our development.”
Dr. Tara Dalton, CEO, Altratech
Altratech has an established relationship with the European Innovation Council, having received a substantial award through the EIC Accelerator Programme in late 2024. Since then, the company has completed a breakthrough pre-clinical HIV study using patient samples in partnership with San Cecilio University Hospital in Spain. This progress builds on the development grant awarded by the Gates Foundation to support digital, point-of-care, multi-analyte molecular viral load testing.
Altratech’s platform is designed to detect and quantify multiple biomarker types, including DNA, RNA, antibodies and antigens, within a single system. By combining nucleic acid detection and serology on one platform, the company aims to enable more comprehensive and accessible point-of-care diagnostics.